PH22808A - Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis( 2-(2-hydroxyethylamino)-ethylamino)anthraquinone, dihydrochloride - Google Patents
Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis( 2-(2-hydroxyethylamino)-ethylamino)anthraquinone, dihydrochlorideInfo
- Publication number
- PH22808A PH22808A PH34969A PH34969A PH22808A PH 22808 A PH22808 A PH 22808A PH 34969 A PH34969 A PH 34969A PH 34969 A PH34969 A PH 34969A PH 22808 A PH22808 A PH 22808A
- Authority
- PH
- Philippines
- Prior art keywords
- hydroxyethylamino
- dihydrochloride
- ethylamino
- anthraquinone
- dihydroxy
- Prior art date
Links
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83724386A | 1986-03-07 | 1986-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH22808A true PH22808A (en) | 1988-12-27 |
Family
ID=25273922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH34969A PH22808A (en) | 1986-03-07 | 1987-03-04 | Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis( 2-(2-hydroxyethylamino)-ethylamino)anthraquinone, dihydrochloride |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0236822B1 (de) |
| JP (1) | JPH0717500B2 (de) |
| KR (1) | KR900002030B1 (de) |
| AT (1) | ATE59290T1 (de) |
| AU (1) | AU593330B2 (de) |
| CA (1) | CA1283607C (de) |
| DE (1) | DE3766984D1 (de) |
| DK (1) | DK166754B1 (de) |
| ES (1) | ES2033247T3 (de) |
| FI (1) | FI84977C (de) |
| GR (1) | GR3001503T3 (de) |
| HK (1) | HK63991A (de) |
| HU (1) | HU199286B (de) |
| IE (1) | IE60025B1 (de) |
| IL (1) | IL81681A (de) |
| NO (1) | NO173635C (de) |
| NZ (1) | NZ219454A (de) |
| PH (1) | PH22808A (de) |
| PT (1) | PT84398B (de) |
| SG (1) | SG45292G (de) |
| ZA (1) | ZA871652B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0705601B1 (de) * | 1994-10-04 | 2000-01-19 | LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik | Lösungen von Anthrachinonen zur parenteralen Applikation |
| DE19818802A1 (de) * | 1998-04-27 | 1999-10-28 | Dresden Arzneimittel | Stabile Mitoxantron-Lösungen |
| TW200526268A (en) * | 2003-12-17 | 2005-08-16 | Takeda Pharmaceutical | Injectable composition |
| CN103260616B (zh) * | 2010-12-09 | 2015-09-09 | 丸石制药株式会社 | 对乙酰氨基酚的稳定化剂 |
| CN114601791B (zh) * | 2020-12-08 | 2023-09-19 | 成都倍特药业股份有限公司 | 一种盐酸米托蒽醌液体制剂及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3230143A (en) * | 1965-05-14 | 1966-01-18 | Merck & Co Inc | Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine |
| US4223022A (en) * | 1978-01-16 | 1980-09-16 | Schering Corporation | Stabilized aminoglycoside antibiotic formulations |
| US4328213A (en) * | 1979-11-28 | 1982-05-04 | Schering Corporation | Stable injectable labetalol formulation |
| ATE48942T1 (de) * | 1984-02-27 | 1990-01-15 | American Cyanamid Co | Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva. |
-
1987
- 1987-02-20 AT AT87102448T patent/ATE59290T1/de not_active IP Right Cessation
- 1987-02-20 ES ES198787102448T patent/ES2033247T3/es not_active Expired - Lifetime
- 1987-02-20 DE DE8787102448T patent/DE3766984D1/de not_active Expired - Lifetime
- 1987-02-20 EP EP87102448A patent/EP0236822B1/de not_active Expired - Lifetime
- 1987-02-26 IL IL81681A patent/IL81681A/xx not_active IP Right Cessation
- 1987-03-02 NZ NZ219454A patent/NZ219454A/en unknown
- 1987-03-04 PT PT84398A patent/PT84398B/pt unknown
- 1987-03-04 PH PH34969A patent/PH22808A/en unknown
- 1987-03-05 CA CA000531200A patent/CA1283607C/en not_active Expired - Lifetime
- 1987-03-06 KR KR1019870002031A patent/KR900002030B1/ko not_active Expired
- 1987-03-06 DK DK116687A patent/DK166754B1/da not_active IP Right Cessation
- 1987-03-06 AU AU69773/87A patent/AU593330B2/en not_active Expired
- 1987-03-06 IE IE56987A patent/IE60025B1/en not_active IP Right Cessation
- 1987-03-06 FI FI870994A patent/FI84977C/fi not_active IP Right Cessation
- 1987-03-06 ZA ZA871652A patent/ZA871652B/xx unknown
- 1987-03-06 NO NO870950A patent/NO173635C/no unknown
- 1987-03-06 JP JP62050398A patent/JPH0717500B2/ja not_active Expired - Lifetime
- 1987-03-06 HU HU87969A patent/HU199286B/hu not_active IP Right Cessation
-
1991
- 1991-02-26 GR GR90400362T patent/GR3001503T3/el not_active IP Right Cessation
- 1991-08-15 HK HK639/91A patent/HK63991A/en not_active IP Right Cessation
-
1992
- 1992-04-24 SG SG45292A patent/SG45292G/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE137963T1 (de) | Lh-rh-analoga enthaltende formulierungen | |
| AR244674A1 (es) | Procedimiento para preparar derivados de acidos 3,4-dihidro-3-tioxo-2h-1,4-bensoxa (o tia)zin-4-aceticos. | |
| FR2695387B1 (fr) | Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| PH22808A (en) | Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis( 2-(2-hydroxyethylamino)-ethylamino)anthraquinone, dihydrochloride | |
| PH23905A (en) | Anticonvulsant agents | |
| DK284588A (da) | Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler. | |
| PH27369A (en) | Glutaric acid derivatives and preparations thereof | |
| ATE64852T1 (de) | Stabile 5-fluorouracil-formulierungen. | |
| ATE75613T1 (de) | 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen. |